author-photo

E. Kalbacher

42

Papers

126

Citations

Citation Trend

Filter By

Papers (28) Sort By

Journal Conference Others

741P Immune features of high-grade ovarian cancer associated with exceptional disease free survival (DFS): An analysis from VIVROVAIRE, a GINECO/GINEGEPS study

2021 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Justification, safety, and efficacy of a third dose of mRNA vaccine in maintenance hemodialysis patients: a prospective observational study

2021 medRxiv
Show All
- Source
- Cite
- Save
Citations (5)
LBA59 LMS-04 study: A randomised, multicenter, phase III study comparing doxorubicin alone versus doxorubicin with trabectedin followed by trabectedin in non-progressive patients as first-line therapy, in patients with metastatic or unresectable leiomyosarcoma - A French Sarcoma Group study

2021 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (1)
LBA58 Results of the randomized, placebo (PL)-controlled phase II study evaluating the efficacy and safety of regorafenib (REGO) in patients (pts) with relapsed advanced or metastatic chordoma, on behalf of the French Sarcoma Group (FSG) and Unicancer

2021 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Long-term safety in patients with recurrent ovarian cancer treated with niraparib versus placebo: Results from the phase III ENGOT-OV16/NOVA trial

2020 Gynecologic Oncology
Show All
- Source
- Cite
- Save
Citations (6)
Renal function improves mortality prediction in acute pulmonary embolism: results of a multicentre cohort study with external validation in the RIETE registry

2020 European Heart Journal
Show All
- Source
- Cite
- Save
Citations (0)
LBA33 Maintenance olaparib plus bevacizumab (bev) in patients (pts) with newly diagnosed advanced high‐grade ovarian carcinoma (HGOC): Final analysis of second progression-free survival (PFS2) in the phase III PAOLA-1/ENGOT-ov25 trial

2020 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (6)
Need for risk-adapted therapy for malignant ovarian germ cell tumors: A large multicenter analysis of germ cell tumors' patients from French TMRG network.

2020 Gynecologic Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Outcomes and incremental prognostic value of renal dysfunction after acute pulmonary embolism

2020 Archives of Cardiovascular Diseases Supplements
Show All
- Source
- Cite
- Save
Citations (1)
LBA68 Results of the randomized, placebo (PL)-controlled phase II study evaluating the efficacy and safety of regorafenib (REG) in patients (pts) with metastatic relapsed Ewing sarcoma (ES), on behalf of the French Sarcoma Group (FSG) and UNICANCER

2020 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (3)